Guggenheim Capital LLC Integra Lifesciences Holdings Corp Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$42.28 - $57.17 $1 Million - $1.36 Million	23,712 Added 448.92%	28,994 $1.23 Million
Q2 2022 Aug 15, 2022	BUY	$53.86 - $66.52 $15,403 - $19,024	286 Added 5.72%	5,282 $285,000
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $31,115 - $34,273	495 Added 11.0%	4,996 $321,000
Q4 2021 Feb 14, 2022	BUY	$62.47 - $73.25 $17,741 - $20,803	284 Added 6.73%	4,501 $302,000
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $273,978 - $321,293	4,217 New	4,217 $289,000
Q2 2021 Aug 13, 2021	SELL	$66.79 - $76.63 $447,225 - $513,114	-6,696 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$62.63 - $71.15 $10,647 - $12,095	170 Added 2.6%	6,696 $463,000
Q4 2020 Feb 16, 2021	SELL	$43.31 - $66.55 $180,212 - $276,914	-4,161 Reduced 38.94%	6,526 $424,000
Q3 2020 Nov 13, 2020	BUY	$43.33 - $51.72 $138,656 - $165,504	3,200 Added 42.74%	10,687 $505,000
Q2 2020 Aug 14, 2020	BUY	$41.42 - $55.57 $75,384 - $101,137	1,820 Added 32.12%	7,487 $352,000
Q1 2020 Jun 02, 2020	SELL	$36.67 - $61.04 $86,027 - $143,199	-2,346 Reduced 29.28%	5,667 $253,000
Q4 2019 Feb 14, 2020	SELL	$55.73 - $62.49 $746,670 - $837,241	-13,398 Reduced 62.58%	8,013 $467,000
Q3 2019 Nov 14, 2019	SELL	$53.29 - $64.59 $184,010 - $223,029	-3,453 Reduced 13.89%	21,411 $1.29 Million
Q2 2019 Aug 14, 2019	SELL	$46.45 - $55.85 $101,168 - $121,641	-2,178 Reduced 8.05%	24,864 $1.39 Million
Q1 2019 May 15, 2019	BUY	$42.97 - $57.33 $191,946 - $256,093	4,467 Added 19.79%	27,042 $1.51 Million
Q4 2018 Feb 14, 2019	BUY	$42.62 - $64.51 $568,977 - $861,208	13,350 Added 144.72%	22,575 $1.02 Million
Q3 2018 Nov 14, 2018	BUY	$57.63 - $65.87 $178,076 - $203,538	3,090 Added 50.37%	9,225 $608,000
Q2 2018 Aug 14, 2018	SELL	$54.05 - $67.23 $216,200 - $268,920	-4,000 Reduced 39.47%	6,135 $394,000
Q1 2018 May 15, 2018	SELL	$46.55 - $57.38 $32,259 - $39,764	-693 Reduced 6.4%	10,135 $562,000
Q4 2017 Feb 14, 2018	SELL	$46.22 - $51.77 $73,998 - $82,883	-1,601 Reduced 12.88%	10,828 $518,000
Q3 2017 Nov 14, 2017	BUY	$47.8 - $53.63 $594,106 - $666,567	12,429	12,429 $629,000

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$249 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$172 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$116 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$93.4 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$87.9 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account